Amgen (AMGN) PT Raised to $184 at Morgan Stanley; 'Adjusting Model for Biosimilar Neulasta Delay'
Tweet Send to a Friend
Morgan Stanley raised its price target on Amgen (NASDAQ: AMGN) to $184.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
